The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial
Abstract
OBJECTIVE: Previous studies have shown a positive effect of zinc as an adjunctive therapy on reducing depressive symptoms. However, to our knowledge, no study has examined the effect of zinc monotherapy on mood. The aim of the present study was to determine the effects of zinc monotherapy on depressive symptoms and serum brain-derived neurotrophic factor (BDNF) levels in overweight or obese subjects. METHODS: Fifty overweight or obese subjects were randomly assigned into two groups and received either 30 mg zinc or placebo daily for 12 weeks. At baseline and post-intervention, depression severity was assessed using Beck depression inventory II (BDI II), and serum BDNF and zinc levels were determined by enzyme-linked immunosorbent assay and atomic absorption spectrophotometry, respectively. RESULTS: The trial was completed with 46 subjects. After a 12-week supplementation, serum zinc and BDNF levels increased significantly in the zinc-supplemented group compared with the placebo group. BDI scores declined in both the groups at the end of the study, but reduction in the zinc-supplemented group was significantly higher than the placebo group. More analysis revealed that following supplementation, BDI scores decreased in subgroup of subjects with depressive symptoms (BDI ≥ 10) (n = 30), but did not change in the subgroup of non-depressed subjects (BDI < 10) (n = 16). Moreover, a significant inverse correlation was observed between serum BDNF levels and depression severity in all participants. Interestingly, a significant positive correlation was found between serum BDNF and zinc levels at baseline. CONCLUSION: Zinc monotherapy improves mood in overweight or obese subjects most likely through increasing BDNF levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.-M. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00005-7 · Cited by 1,232
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151
Castrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Ghassemzadeh, H., Mojtabai, R., Karamghadiri, N., & Ebrahimkhani, N. (2005) · Depression and Anxiety · doi:10.1002/da.20070 · Cited by 813
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667
Research works printed but not linked: 4
- Sadeghirad B, 2010, Int J Prev Med, 1, 81
- Nowak G, 2003, Pol J Pharmacol, 55, 1143
- Booth ML, 2003, Med Sci Sports Exerc, 195, 1381
- Cieślik K, 2006, Pharmacol Rep, 59, 46
Cited by
Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Porter, G. A., & O’Connor, J. C. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.77 · Cited by 178
Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis
Numakawa, T., Odaka, H., & Adachi, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112312 · Cited by 173
“It has been reported that zinc supplementation increased the serum BDNF levels and improved depressive symptoms in obese or overweight subjects [31].”
BackgroundLogan, A. C., & Jacka, F. N. (2014) · Journal of Physiological Anthropology · doi:10.1186/1880-6805-33-22 · Cited by 168
Walsh, E. I., Smith, L., Northey, J., Rattray, B., & Cherbuin, N. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101044 · Cited by 162
“…associations between dietary supplementation and increased peripheral BDNF have been reported (e.g. Chung et al., 2012; Sandberg et al., 2018; Solati et al., 2015), such as omega-3 polyunsaturated fatty acids (3- PUFA; found in foods such as fish and flaxseed oil), with reported increases of…”
Dietary Nutrient Deficiencies and Risk of Depression (Review Article 2018–2023)
Zielińska, M., Łuszczki, E., & Dereń, K. (2023) · Nutrients · doi:10.3390/nu15112433 · Cited by 180
“In addition, zinc influences hormonal regulation, including cortisol levels, cellular immune response, neurogenesis, neuronal plasticity, and expression of BDNF in the hippocampus and cortex, and zinc ions regulate synaptic transmission or act as neurotransmitters [128].”
Metadata
- Authors
- Solati, Z., Jazayeri, S., Tehrani-Doost, M., Mahmoodianfard, S., & Gohari, M. R.
- Affiliations
- Tehran University of Medical Sciences (IR)
- Iran University of Medical Sciences (IR)
- Corresponding author
- Jazayeri, Shima
- Venue
- Nutritional Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2014-01-07
- Volume
- 18
- Issue
- 4
- Pages
- 162-168
- ISSN
- 1028-415X (ISSN-L)
- 1476-8305
- OpenAlex
- W2086142993
- Cited by
- 104
- References
- 42
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 3 · 2023: 10 · 2022: 13 · 2021: 8 · 2020: 5 · 2019: 10 · 2018: 8 · 2017: 7 · 2016: 13 · 2015: 13 · 2014: 3
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutritional Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- zinc supplementation, brain-derived neurotrophic factor, depressive symptoms, depression, overweight, obesity, serum zinc, mood, adjunctive therapy
- MeSH terms
- Adult, Depression, Double-Blind Method, Female, Humans, Male, Middle Aged, Obesity, Psychiatric Status Rating Scales, Zinc, Brain-Derived Neurotrophic Factor, Dietary Supplements, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. https://app.cochat.ai/papers/10.1179/1476830513y.0000000105
- The paper
- Solati, Z., Jazayeri, S., Tehrani-Doost, M., Mahmoodianfard, S., & Gohari, M. R. (2015). Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial. Nutritional Neuroscience. https://doi.org/10.1179/1476830513y.0000000105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.